Patents by Inventor Joonsun LEE

Joonsun LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGET-SPECIFIC CRISPR MUTANT
    Publication number: 20230130858
    Abstract: The present invention relates to an artificially engineered CRISPR/Cas9 system. More particularly, the present invention relates to an artificially engineered CRISPR enzyme having enhanced target specificity and a use of an artificially engineered CRISPR/Cas9 system including the same enzyme in genome and/or epigenome manipulation or modification, genome targeting, genome editing, and in vitro diagnosis, etc.
    Type: Application
    Filed: August 3, 2022
    Publication date: April 27, 2023
    Inventors: Young-Hoon KIM, Min Hee JUNG, Joonsun LEE, Eunji SHIN, Kang In LEE, Seokjoong KIM, Jeongjoon LEE
  • Target-specific CRISPR mutant
    Patent number: 11441135
    Abstract: The present invention relates to an artificially engineered CRISPR/Cas9 system. More particularly, the present invention relates to an artificially engineered CRISPR enzyme having enhanced target specificity and a use of an artificially engineered CRISPR/Cas9 system including the same enzyme in genome and/or epigenome manipulation or modification, genome targeting, genome editing, and in vitro diagnosis, etc.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: September 13, 2022
    Assignee: TOOLGEN INCORPORATED
    Inventors: Young-Hoon Kim, Min Hee Jung, Joonsun Lee, Eunji Shin, Kang In Lee, Seokjoong Kim, Jeongjoon Lee
  • TARGET-SPECIFIC CRISPR MUTANT
    Publication number: 20200149022
    Abstract: The present invention relates to an artificially engineered CRISPR/Cas9 system. More particularly, the present invention relates to an artificially engineered CRISPR enzyme having enhanced target specificity and a use of an artificially engineered CRISPR/Cas9 system including the same enzyme in genome and/or epigenome manipulation or modification, genome targeting, genome editing, and in vitro diagnosis, etc.
    Type: Application
    Filed: July 6, 2018
    Publication date: May 14, 2020
    Inventors: Young-Hoon KIM, Min Hee JUNG, Joonsun LEE, Eunji SHIN, Kang In LEE, Seokjoong KIM, Jeongjoon LEE